Improving survival among HIV-infected injection drug users: how should we define success?
Kirk
Gregory D
GD
Vlahov
David
D
D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000821:virology*; D017741:Survivors